Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 8Observational 2Expanded_access 1

Sponsor

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Oncogenic osteomalacia × Clear all
NCT04783428 2026-06-03

Tumor-induced Osteomalacia Disease Monitoring Program

Ultragenyx Pharmaceutical Inc

Active not recruiting
23 enrolled

Oncogenic osteomalacia

NCT00099762 2017-07-02

Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia

National Institutes of Health Clinical Center (CC)

Completed
45 enrolled

Oncogenic osteomalacia, Neoplasms, Osteomalacia, Hypophosphatemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡